0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Toxicology
 1-20 of 331 Articles
Research Letter | 
Andrew Fenelon, PhD; Li-Hui Chen, PhD; Susan P. Baker, MPH
JAMA. 2016;315(6):609-611. doi:10.1001/jama.2015.15564.

News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(6):550. doi:10.1001/jama.2016.0085.

The JAMA Forum |  FREE
Howard Koh, MD, MPH
JAMA. 2015;314(14):1437-1438. doi:10.1001/jama.2015.12346.

Original Investigation | 
Beth Han, MD, PhD, MPH; Wilson M. Compton, MD, MPE; Christopher M. Jones, PharmD, MPH; et al.
JAMA. 2015;314(14):1468-1478. doi:10.1001/jama.2015.11859.
Includes: CME, Supplemental Content

News From the Centers for Disease Control and Prevention | 
JAMA. 2015;314(6):550. doi:10.1001/jama.2015.9007.

Capitol Health Call | 
Laura Buchholz
JAMA. 2015;314(2):115. doi:10.1001/jama.2015.7535.

Medical News & Perspectives | 
Rita Rubin, MA
JAMA. 2015;313(23):2309-2310. doi:10.1001/jama.2015.3911.

News From the Food and Drug Administration | 
Rita Rubin, MA
JAMA. 2015;313(17):1704. doi:10.1001/jama.2015.4112.

News From the Centers for Disease Control and Prevention | 
JAMA. 2015;313(9):886. doi:10.1001/jama.2015.0700.

Viewpoint | 
John A. Rogers, PhD, SM
JAMA. 2015;313(6):561-562. doi:10.1001/jama.2014.17915.

Viewpoint | 
Andrew A. Monte, MD; Richard D. Zane, MD; Kennon J. Heard, MD, PhD
JAMA. 2015;313(3):241-242. doi:10.1001/jama.2014.17057.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(24):2608. doi:10.1001/jama.2014.17033.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(23):2482. doi:10.1001/jama.2014.16135.

News From the Centers for Disease Control and Prevention | 
JAMA. 2014;312(15):1504. doi:10.1001/jama.2014.12463.

The Art of JAMA | 
Jeanette M. Smith, MD
JAMA. 2014;312(13):1280-1281. doi:10.1001/jama.2013.279755.

Health Agencies Update | 
Bridget M. Kuehn, MSJ
JAMA. 2014;312(12):1185. doi:10.1001/jama.2014.12756.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10967.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2014;312(8):779. doi:10.1001/jama.2014.10968.

JAMA Revisited | 
JAMA. 2014;312(8):850. doi:10.1001/jama.2013.279692.

Global Health | 
M. J. Friedrich
JAMA. 2014;312(7):687. doi:10.1001/jama.2014.9498.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncology
Invited Commentary  | 
Biomarkers of Fluorouracil Toxicity Insight From the PETACC-8 Trial
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncology
Original Investigation  | 
DPYD Genotyping to Predict Adverse Events Following Treatment With Flourouracil-Based Adjuvant Chemotherapy in Patients With Stage III Colon Cancer A Secondary Analysis of the PETACC-8 Randomized Clinical Trial
Valérie Boige, MD, PhD; Marc Vincent, PhD; Philippe Alexandre, MS; et al.